Drug Profile
Islet cell replacement therapy - Sernova
Alternative Names: Cell Pouch™ - donor islet cells; Islands-of-Langerhans transplantation; Islet cell therapy; Islet transplantation; Islet-of-Langerhans cell replacement therapy; Islets-of-Langerhans transplantation; Pancreatic islets transplantationLatest Information Update: 31 Oct 2023
Price :
$50
*
At a glance
- Originator Sernova Corp
- Developer Sernova Corp; University of Alberta; University of Chicago
- Class Antihyperglycaemics; Cell therapies
- Mechanism of Action Pancreatic beta cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Haemophilia A; Type 1 diabetes mellitus
Highest Development Phases
- Phase I/II Type 1 diabetes mellitus